Icon
+91 94997 68112
Login Register

ARISTADA (nda207533)- (441MG/1.6ML (275.63MG/ML),662MG/2.4ML (275.83MG/ML),882MG/3.2ML (275.63MG/ML),1064MG/3.9ML (272.82MG/ML))

ARIPIPRAZOLE LAUROXIL ALKERMES INC
441MG/1.6ML (275.63MG/ML),662MG/2.4ML (275.83MG/ML),882MG/3.2ML (275.63MG/ML),1064MG/3.9ML (272.82MG/ML)
No Yes
2039-Apr-06 2020-Oct-05
None None
None No
ARISTADA is an atypical antipsychotic indicated for the treatment of schizophrenia.
0 0 0
Total Other Developers 6
Drugs with Suitability No
441MG/1.6ML (275.63MG/ML) ** ** Up - -
662MG/2.4ML (275.83MG/ML) ** ** Up - -
882MG/3.2ML (275.63MG/ML) ** ** Up - -
1064MG/3.9ML (272.82MG/ML) ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.